Sun, Jul 13, 2014, 9:12 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bootpart bootpart Feb 29, 2012 8:03 AM Flag

    Today's Citi investor presentation

    The FDA will always let a company know if early approval is likely. The company has to prepare for launch and for a drug like Kalydeko the last thing you want is for an approval to be handed down and then the patients have to wait 2 months while the company reacts to the early approval. The hard part is keeping it quiet which Vertex seemed to do very well as nobody on wall st had any idea. It's a good model, works for the patients.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • love to know the initial rollout of Kalydeco....

      and more regular current updates on Incevik...

      since it is so critical to investors' decision making, I've always wondered why companies can't find it useful to release actual fact/data based information on sales as they happen....weekly, monthly....why in this day of instant and verifiable data do we need to wait 90 days to know what those on wall street can see if they subscribe to certain outlets or have the COO or CFO cell number?

 
VRTX
99.07+1.25(+1.28%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.